FDA Clearance Tracker · DEN140016
STUDIO ON THE CLOUD DATA MANAGEMENT SOFTWARE
Last checked: Nov 20, 2026Latest source record: Aug 19, 2014 (this decision)Source: openFDAMethods & limitations
Decided
Aug 19, 2014
De Novo granted
Time to decision
119 days
Received Apr 22, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class I
The decision
- FDA number
- DEN140016
- Device name
- STUDIO ON THE CLOUD DATA MANAGEMENT SOFTWARE
- Applicant
- Dexcom, Inc.
- Applicant location
- San Diego, CA
- Received
- Apr 22, 2014
- Decided
- Aug 19, 2014
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class I
- Regulation
- 21 CFR 862.2120
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN140016
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Dexcom, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262472 · Decided Aug 11, 2026 · 25 days after receipt
Device type: Integrated Continuous Glucose Monitor For Non-Intensive Glucose Management, Over-The-Counter (SBH) · Laboratory Medicine & Pathology
K260935 · Decided Jun 12, 2026 · 84 days after receipt
Device type: Integrated Continuous Glucose Monitor For Non-Intensive Glucose Management, Over-The-Counter (SBH) · Laboratory Medicine & Pathology
- Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System510(k)
K261402 · Decided Jun 8, 2026 · 40 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.